Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > I have a 40 page LABS research / valuation report available

<< Previous

Bullboard Posts

Next >>

Comment by alleyesonmeon Nov 22, 2023 10:18am

110 Views

Post# 35748279

RE:RE:RE:RE:RE:I have a 40 page LABS research / valuation report available

I've previously consider the risks of synthetic CBD and have discounted such threat because....consumers always opt for "natural" compounds when given choice...sythentic CBD is costly and epidiolex..all trials I've seen are for naturally derived cannabiniods.....I really don't see synthetic ever taking over...the whole beauty of the industry is Natural...no one wants synthetic...some will try but it won't take hold. iMO

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments